Specialty: Primary Care, Primary sub-specialty: Health services and delivery research
Conditions
Interventions
After recruitment participants will be randomly assigned to two groups in a 1:1 ratio, statified by gender (men
other)
Intervention group: Participants will be invited to attend a group structured education programme - the MAP programme. They will also receive regular motivational text messages during the stud
Sponsors
University of Leicester
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Good understanding in written and verbal English 2. Able to give informed consent 3. 40-85 years old inclusive 4. Have two or more chronic conditions 5. Have access to a mobile phone for use in potential study activities 6. Able to walk independently
Exclusion criteria
Exclusion criteria: 1. Limited understanding of written and verbal English 2. Dementia, learning disability, mental health disorders other than depression or epilepsy 3. Palliative care 4. Pregnancy 5. Currently participating or participated in another interventional trial in the previous 12 weeks 6. Patients with frailty. The definition of frailty will be at the investigator’s discretion and based on patients: 6.1. Living in care homes or institutions 6.2. Having support for daily activities such as washing, cooking, household tasks etc. 6.3. Having had unintentional significant weight loss in the last 3-6 months 6.4. Having BMI less than 18.5kg/m2
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Current version as of 06/04/2018: 1. Self-efficacy for managing chronic disease and exercise is measured by Chronic Disease Self-efficacy Scales at baseline, 6 and 12 months 2. Medication adherence is measured using the ASK 12 (Adherence Starts with Knowledge) Questionnaire at baseline and 12 months 3. Quality of life is measured using the HADS and EQ-5D-5L questionnaires at baseline and 12 months 4. Lifestyle behaviours other than physical activity will be measured by food intake and sleeping pattern questions at baseline and 12 months Original version: 1. Self-efficacy for managing chronic disease and exercise is measured by Chronic Disease Self-efficacy Scales at baseline, 6 and 12 months 2. Medication adherence is measured by The Morisky Medication Adherence scale (MMAS-8) at baseline and 12 months 3. Quality of life is measured using the HADS and EQ-5D-5L questionnaires at baseline and 12 months 4. Lifestyle behaviours other than physical activity will be measured by food intake and sleeping pattern questions at baseline and 12 months | — |
Primary
| Measure | Time frame |
|---|---|
| Average daily physical activity is measured using an accelerometer and physical activity questionnaires (RPAQ and SEE) at baseline and 12 months | — |
Countries
England, United Kingdom
Contacts
Public ContactPatrick Highton
Outcome results
None listed